Sunny Pharmtech Inc.
TWO: 6676.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Yon-Lian Wu
- Employees
- 154
- Headquarters
- Taoyuan, Taiwan
- IPO year
- 2022
- Market cap
- NT$2.2B
- Website
- https://www.sunnypharmtech.com
Loading 6676…
Loading profile data…Frequently asked questions about 6676
What does Sunny Pharmtech Inc. (6676.TWO) do?
Sunny Pharmtech Inc. engages in the research, development, production, and sale of drug substances and products, and active pharmaceutical ingredients in Taiwan and internationally. Its products portfolio include lidocaine ointment that can be used as an anesthetic lubricant for intubation, which temporarily relieves pain associated with minor b...
Where does 6676.TWO trade?
Sunny Pharmtech Inc. (6676.TWO) trades on the Taipei Exchange.
What sector is 6676.TWO in?
Sunny Pharmtech Inc. (6676.TWO) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Sunny Pharmtech Inc.?
Yon-Lian Wu is the chief executive officer of Sunny Pharmtech Inc. (6676.TWO).
Where is Sunny Pharmtech Inc. headquartered?
Sunny Pharmtech Inc. is headquartered in Taiwan.
Does 6676.TWO pay a dividend?
Sunny Pharmtech Inc. (6676.TWO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 6676.TWO go public?
Sunny Pharmtech Inc. (6676.TWO) completed its initial public offering in 2022.